ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)
| 23.64 Delayed Data As of Sep 26 |  +0.34 / +1.46%Today’s Change | 13.73 Today|||52-Week Range 33.99 | +48.49% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 102.1M | 163.6M | 69.4M | 134.8M | |
| Short Term Investment Cash | 40.3M | 63.5M | -94.1M | 67.7M | ||
| Cash & Short Term Investments | 215.1M | 529.0M | 341.3M | 473.5M | ||
| Receivables | Receivables | 1.6M | 7.1M | 18.4M | 27.8M | |
| Inventories | Inventories | 0.00 | 4.2M | 5.2M | 4.1M | |
| Current Assets | Prepaid Expenses | -- | -- | 8.5M | 20.7M | |
| Other Current Assets | 2.2M | 7.5M | -- | -- | ||
| Current Assets | 219.0M | 547.9M | 373.5M | 526.1M | ||
| Total Assets | Property, Plant and Equipment - Gross | 5.0M | 6.5M | 6.9M | 7.5M | |
| Depreciation | -2.8M | -3.4M | -4.2M | -4.2M | ||
| Intangible Assets | -- | 7.0M | 5.5M | 4.1M | ||
| Other Assets | 329.0K | 7.8M | 5.9M | 6.0M | ||
| Total Assets | 221.9M | 561.2M | 384.5M | 540.2M | ||
| Liabilities | Accounts Payable | 1.7M | 3.9M | 8.8M | 3.2M | |
| Accrued Expenses | 14.5M | 21.6M | 21.4M | 33.5M | ||
| Other Current Liabilities | 14.5M | 24.3M | 21.4M | 33.5M | ||
| Other Liabilities | 21.9M | 42.6M | 49.0M | 59.6M | ||
| Total Liabilities | Other Liabilities | 232.0K | 157.0K | 191.0K | 1.6M | |
| Total Liabilities | 22.1M | 42.7M | 49.2M | 61.1M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 199.8M | 518.4M | 335.3M | 479.1M | ||
| Total Shareholder Equity | 199.8M | 518.4M | 335.3M | 479.1M | ||
| Share Information | Common Shares Outstanding | 101.9M | 121.4M | 124.4M | 143.9M | |
| Addtl. Info. | No data currently available for this section. | |||||
